- 1 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2003/03/11(²Ð) 22:53
ºÇ¿·¤Î¸¡ººÊýË¡¤òÏÃÂê¤È¤¹¤ë¥¹¥ì¥Ã¥É
- 48 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2005/08/22(·î) 12:37
- >>46
¾Ç¤Ã¤Æ¤ª¤é¤ì¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¤È»×¤¤¤Þ¤¹¤¬ ¾¯¡¹Åª³°¤ì¤Ê¸¡ºº¤Ç¤Ï¤Ê¤¤¤«¤È¡£ ¼ç¼£°å¤Ë¤Þ¤º¤´ÁêÃ̲¼¤µ¤¤¡£
- 49 ̾Á°¡§ ¤¬¤à Åê¹ÆÆü¡§2005/08/22(·î) 12:59
- >47¤µ¤ó¡¢
°Ê²¼¤ÏÊÆ¹ñ¤ÎÃøÌ¾¤Ê¸ý¹Ð¥¬¥óÉÂÍý¸¦µæ½ê¤ÎWEB¥µ¥¤¥È¤Îµ½Ò¤Ç¤¹¡£ ¤´»²¹Í¤Þ¤Ç¤Ë¡¨
Bony surface proliferations found in another site are typically given the generic diagnosis of bony exostosis or osteoma, i.e. are considered to be trauma-induced inflammatory periosteal reactions or true neoplasms. Unless such a bony prominence is specifically located, is pedunculated or is associated with an osteoma-producing syndrome such as the Gardner syndrome, there may be no means by which to differentiate an exostosis from an osteoma,
(¾Êά¤µ¤ì¤Þ¤·¤¿¡¦¡¦Á´¤Æ¤òÆÉ¤à¤Ë¤Ï¤³¤³¤ò²¡¤·¤Æ¤¯¤À¤µ¤¤)
- 50 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2005/08/23(²Ð) 09:30
- >>46
¼À´µ¤Ë¤è¤Ã¤Æ¤Ï¡ÊǾ¹¼ºÉ¡¢ç¹±ê¡¢ÂçÆ°Ì®²òÎ¥¡¢ÇÙºÉÀò¡Ë1½µ´Ö ¤Ë2²ó¡¢¤â¤·¤¯¤Ï¤½¤ì°Ê¾å¤ÎCT¤ò»£¤ë¤³¤È¤ÏÅö¤¿¤êÁ°¤Ç¤¹¡£ ÅöÁ³ÈïÇú¤â¤¢¤ê¡¢¶»¤Îñ½ã¼Ì¿¿¤ÎÈæ¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£ ¥ê¥¹¥¯¤È¥Ù¥Í¥Õ¥£¥Ã¥È¤ò¹Íθ¤·¡¢É¬Íפʤé¼õ¤±¤é¤ì¤¿¤é Ç¡²¿¤Ç¤·¤ç¤¦¤«¡£µ®Êý¤¬´µ¼Ô¤Ê¤é¡¢¤³¤¦¤¤¤¦»þ¤³¤½ ¼ç¼£°å¤Ë¿Ò¤Í¤ë¤Ù¤¤Ç¤Ï¡©
- 51 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2005/08/23(²Ð) 09:31
- ¤¢¡¢°ß¥«¥á¥é¤ÈͲ»ÇȤˤ·¤Æ¤ª¤¤¤¿¤é¤É¤¦¤Ç¤¹¤«¤Í¡£
- 52 ̾Á°¡§ ¤ê¤ê Åê¹ÆÆü¡§2005/08/30(²Ð) 19:20
- ͧã¤Î¤ªÊ줵¤ó¤¬Åݤì¡ÖIJÊĺɡפȤÎȽÃǤÀ¤Ã¤¿¤é¤·¤¤¤Î¤Ç¤¹¤¬¡¢¼ðá礬¥¬¥ó¤À¤È¸À¤ï¤ì¤¿¤é¤·¤¯¡¢Å¾°Ü¤·¤½¤¦¤Ê¤ó¤Ç¡¢ÌÀÆü¼ê½Ñ¤Ê¤ó¤À¤½¤¦¤Ç¤¹¡£ºòÆü¡¢Åݤì¤é¤ì¤¿¤é¤·¤¤¤ó¤Ç¤¹¤¬¡Ä¤½¤ó¤Ê¤ËÁ᤯¥¬¥ó¤À¤ÈȽÌÀ¤¹¤ë¤â¤Î¤Ê¤ó¤Ç¤·¤ç¤¦¤«¡©ÌµÃΤǤ¹¤ß¤Þ¤»¤ó¡£
- 53 ̾Á°¡§ % Åê¹ÆÆü¡§2005/09/01(ÌÚ) 07:52
- How about PET?
- 54 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2005/09/01(ÌÚ) 11:09
- >>52
¼ðá礬°À¤«Èݤ«¤Ï¡¢ºÙ˦¤äÁÈ¿¥¤ò¸²Èù¶À¤Ç¸«¤ÆÈ½ÃǤ·¤Þ¤¹¡£ ½ÑÃæ¿×®¿ÇÃǤȤ¤¤¦¤â¤Î¤â¸ºß¤·¤Þ¤¹¤Î¤Ç¡¢¤½¤ÎÆü¤Î¤¦¤Á¤Ë ¿ÇÃǤ¬¤Ä¤¯¤È¤¤¤¦¤³¤È¤Ï¡¢¤¢¤ê¤¨¤Ê¤¤¤³¤È¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡Ä¡£
´â¤À¤È¿ÇÃǤµ¤ì¤¿Íýͳ¤ò¤ª¿Ò¤Í¤Ë¤Ê¤ë¤Î¤¬¤è¤í¤·¤¤¤È»×¤¤¤Þ¤¹¡£ ¡ÖºÙ˦¿Ç¡×¤È¤¤¤¦¿ÇÃǤǡ֥¯¥é¥¹£µ¡×¤¬°À¼ðáç¤Ç¤¹¡£ ¤Ç¤¤ì¤Ð¡¢ÉÂÍýÉô¤Ç¥×¥ì¥Ñ¥é¡¼¥È¤ò¸«¤»¤Æ¤¤¤¿¤À¤¡¢ÀâÌÀ¤·¤Æ¤¤¤¿¤À¤¯¤Î¤¬ ¥Ù¥¹¥È¤Ç¤¹¡£
- 55 ̾Á°¡§ ¤Ï¤ë Åê¹ÆÆü¡§2005/09/05(·î) 01:28
- ËͤÏâдݼðáç¤Ê¤ó¤Ç¤¹¤¬°ìÈֻϤá¤ËâдݤòŦ½Ð¤·¤¿¤ó¤Ç¤¹¤±¤É¥ê¥ó¥Ñ¤Ë¤âž°Ü¤¬¤¢¤Ã¤¿¤«¤é¹³¤¬¤óºÞ¤ò»È¤Ã¤Æ¼ðáç¥Þ¡¼¥«¡¼¤¬Àµ¾ï²½¤·¤Þ¤·¤¿¡£¤Ç¤âCT¤Ë¤Ï¤Þ¤À¤«¼ðá礬»Ä¤Ã¤Æ¤¤¤¿¤Î¤ÇŦ½Ð¤·¤¿¤ó¤Ç¤¹¡£¤½¤ì¤ÇºÙ˦¤ÎÉÂÍý¸¡ºº¤Î·ë²Ì¤Ï°¤¤ºÙ˦¤Ï¤¤¤Ê¤«¤Ã¤¿¤Æ¤æ¤ï¤ì¤¿¤ó¤Ç¤¹¤±¤É¤½¤ì¤Ï¤è¤«¤Ã¤¿¤ó¤Ç¤¹¤«¤Í¡©
- 56 ̾Á°¡§ ̵̾¤·¤µ¤ó Åê¹ÆÆü¡§2008/04/27(Æü) 02:52
- Ç¢¤Ë¤è¤ë´â¿ÇÃǡʥ¥Ã¥³¡¼¥Þ¥ó¡Ë
http://health.nikkei.co.jp/news/med/index.cfm?i=2008041009155hb
¥¥Ã¥³¡¼¥Þ¥ó¤Ï¡¢¤¬¤óȯÀ¸¤Î»ØÉ¸¤È¤Ê¤ëÇ¢Ãæ¤Î²½³ØÊª¼ÁÎ̤ò¬Äꤹ¤ë¤¿¤á¤Î ¹ÚÁǤòºî¤ê½Ð¤¹¤³¤È¤ËÀ®¸ù¤·¤¿¡£ ¤³¤Î¹ÚÁǤòÍøÍѤ¹¤ì¤Ð¡¢½¾Íè¤Î¬ÄêË¡¤è¤ê¤â¡¢´Êñ¤Çû»þ´Ö¤Ë¬¤ë¤³¤È¤¬¤Ç¤¤ë¤È¤¤¤¦¡£ ¸úΨŪ¤Ê¹ÚÁÇÀ¸»º¤òÌܻؤ·¡¢Áá´ü¤Ë¥»¥ó¥µ¡¼¸þ¤±¹ÚÁǤÎȯÇä¤Ë¤Ä¤Ê¤²¤¿¤¤¹Í¤¨¡£
³«È¯¤µ¤ì¤¿¤Î¤Ï¡¢¤¬¤óȯÀ¸¤Î»ØÉ¸¤È¤Ê¤ëÇ¢Ãæ¤Î¥¸¥¢¥»¥Á¥ë¥¹¥Ú¥ë¥ß¥ó¤ËÈ¿±þ¤¹¤ë¹ÚÁÇ¡£ ¥¸¥¢¥»¥Á¥ë¥¹¥Ú¥ë¥ß¥óÇ»Å٤ϡ¢¤¬¤ó´µ¼Ô¤ÎÇ¢Ãæ¤Ç·ò¹¯¤Ê¿Í¤è¤ê¤â¹â¤¯¤Ê¤ë¤È¤·¤Æ¡¢
(¾Êά¤µ¤ì¤Þ¤·¤¿¡¦¡¦Á´¤Æ¤òÆÉ¤à¤Ë¤Ï¤³¤³¤ò²¡¤·¤Æ¤¯¤À¤µ¤¤)
| Ãç´ÖƱ»Î¡¦Èó¸ø³«¤Î·Ç¼¨ÈÄ, ¥Ö¥í¥°,¥¢¥Ð¥¿¡¼,¾·ÂÔ¾õޥޥޥ ¡¡´â·Ç¼¨ÈĤÎSNS 4¡¡ ¡¡ |
|